Neurocysticercosis
📧 Sign up to get email alerts when something new happens for Neurocysticercosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: Treatment of Peri-calcification Edema in Neurocysticercosis (NCC) [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial investigating treatment of peri-calcification edema in neurocysticercosis has been terminated. The document…
-
CLINICAL_TRIALS trial_result · 2024-04-23Clinical Trial Update: Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis [Phase 4]
A Phase 4 trial is planned to assess combining praziquantel with albendazole versus albendazole alone for active parenchymal neurocysticerco…
-
CLINICAL_TRIALS trial_result · 2022-11-16Clinical Trial Update: Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO) [Phase 3]
Phase 3 trial update for subarachnoid neurocysticercosis (SANTO) has been TERMINATED.
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole [Phase 1]
Phase I trial evaluating safety and pharmacokinetics of oxfendazole for neurocysticercosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB [Phase 1]
Phase 1 clinical trial evaluating PET imaging of peripheral benzodiazepine receptors in neurocysticercosis using the tracer [F-18]FB; the st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: People Presenting With Neurocysticercosis in North America
The NIAID-sponsored clinical trial investigating neurocysticercosis in North America has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients [Phase 3]
Phase 3 clinical trial evaluating whether corticosteroids can reduce seizure frequency in neurocysticercosis has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT [Phase 3]
A Phase 3 clinical trial comparing two durations of albendazole therapy in patients with neurocysticercosis (brain involvement with up to 5 …
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis [NA]
A randomized trial evaluated albendazole in patients with epilepsy due to neurocysticercosis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ) [Phase 2, Phase 3]
This clinical trial update reports results from a combined treatment with praziquantel and albendazole for neurocysticercosis and related ep…
-
CLINICAL_TRIALS trial_result · 2010-02-08Clinical Trial Update: A Pilot Study of Neurocysticercosis Treatment [Phase 3]
Phase 3 pilot study evaluating treatment for neurocysticercosis has completed.